Diabetes & CV Disease
Sort by:
Omnipod®
American Diabetes Association TV- Omnipod DASH® System
FEATURING
Anders Carlson,
Diana Isaacs
- 136 views
- February 24, 2022
Omnipod®
Clinical Perspectives on Insulin-Requiring Patients with Type 2 Diabetes
FEATURING
Michael Heile
- 330 views
- February 24, 2022
- 2
Emory Diabetes Education Training Academy
Update in Diabetes and Cardiovascular Health
FEATURING
Guillermo Umpierrez
- 2,117 views
- February 17, 2022
- 11
Scripps Health
Cognitive-Behavioral Modification for Weight Management
FEATURING
Joseph Kearney
- 197 views
- February 17, 2022
- 1
Omnipod®
ADA/AACE Guidelines for T2DM Pump Therapy, Medicare Coverage and New Clinical Data on the Omnipod DASH® System (2/4)
FEATURING
Diana Isaacs
- 158 views
- February 17, 2022
Omnipod®
Practice Use and Considerations using the Omnipod DASH® System from Both the T2DM Patient, and the Prescriber Perspective (4/4)
FEATURING
Diana Isaacs
- 139 views
- February 17, 2022
Omnipod®
Omnipod DASH® System Case Study: How I Initiate, Treat, and Follow Up with T2DM Patients Who Need a Pump (3/4)
FEATURING
Diana Isaacs
- 311 views
- February 17, 2022
- 2
Omnipod®
Updates to the Omnipod DASH® System and Relevant Supportive Tools for T2DM Patients (1/4)
FEATURING
Diana Isaacs
- 210 views
- February 17, 2022
- 1
American College of Cardiology
ESC Congress 2021: MASTER DAPT, ENVISAGE-TAVI AF and FIGARO-DKD Trials
FEATURING
Deepak Bhatt,
Philippe Gabriel Steg
- 16 views
- February 15, 2022
American College of Cardiology
Management of Patients With HFpEF: EMPEROR-Preserved Trial
- 351 views
- February 15, 2022
- 5
American College of Cardiology
FIGARO-DKD Trial: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
- 218 views
- February 15, 2022
- 2
Cedars Sinai
Cardiac Care in Women: Emerging Risk Factors
FEATURING
Dipti Itchhaporia
- 15 views
- February 8, 2022
Cedars Sinai
Role of Finerenone for Mitigating Cardiorenal Risk in T2 Diabetes
FEATURING
Sanjay Kaul,
George Bakris
- 707 views
- February 7, 2022
- 4
Cedars Sinai
SGLT2 Inhibitors: Are They the Modern-Day Statins? Insights from Recent Cardiorenal Metabolic Outcome Trial
FEATURING
Sanjay Kaul,
Milton Packer
- 1,787 views
- February 7, 2022
- 9
Cedars Sinai
What Diet Is Best for Cardiovascular Health?
FEATURING
Kim Williams
- 1,742 views
- February 4, 2022
- 14
Cleveland Clinic Endocrinology & Metabolism Institute
The Challenge of Hypertriglyceridemia
FEATURING
Michelle Lundholm
- 1,794 views
- January 27, 2022
- 10
Houston Methodist DeBakey Heart and Vascular Center
Aspirin for the Primary Prevention of Cardiovascular Disease: What Changed?
FEATURING
Michael Miedema
- 3,411 views
- January 25, 2022
- 26
Piedmont Heart Institute
Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i
FEATURING
Jaime Burkle
- 1,786 views
- January 25, 2022
- 19
KDIGO
Kidney Benefits Associated With Current Pharmacotherapies in Patients With CKD and Diabetes
FEATURING
Peter Rossing
- 129 views
- January 24, 2022
- 1
KDIGO
Cardiovascular Benefits Associated with Current Pharmacotherapies in Patients with CKD and Diabetes
FEATURING
Erin Michos
- 345 views
- January 24, 2022
- 4
KDIGO
SGLT2 Inhibitors and GLP-1 Receptor Agonists: Different Classes, Different Modes of Kidney Protection
FEATURING
Hiddo Lambers Heerspink
- 544 views
- January 24, 2022
- 6
